Cognitive behavioral therapy for adults with attention-deficit hyperactivity disorder: study protocol for a randomized controlled trial

被引:3
|
作者
Huang, Fang [1 ,2 ]
Qian, Qiujin [1 ,2 ]
Wang, Yufeng [1 ,2 ]
机构
[1] Peking Univ, Hosp 6, Natl Clin Res Ctr Mental Disorders, Inst Mental Hlth, Beijing 100191, Peoples R China
[2] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100191, Peoples R China
关键词
Attention-deficit hyperactivity disorder (ADHD); cognitive behavioral therapy (CBT); booster sessions; randomized controlled trial; MEDICATION-TREATED ADULTS; DEFICIT/HYPERACTIVITY DISORDER; RECURRENT DEPRESSION; ADHD; SYMPTOMS; QUALITY; ANXIETY; LIFE; PSYCHOTHERAPY; PREVALENCE;
D O I
10.1186/s13063-015-0686-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Attention-deficit hyperactivity disorder (ADHD) is a mental disorder beginning in childhood, and about half of patients have symptoms lasting into adulthood. Adult ADHD causes various impairments of emotional, self-esteem, and executive function and life quality aspects. Furthermore, adverse outcomes include academic and occupational failures, traffic accidents and substance abuse, which would be a family and social burden. A combination of medication and psychotherapy is recommended as the treatment for adult ADHD, and cognitive behavioral therapy (CBT) has been validated mostly with evidence-based researches. However, there has been a lack of randomized controlled trials of CBT for patients in China. Moreover, booster sessions of CBT for other disorders have proven effective in reducing recurrence and improving long-term outcomes, which has not been investigated for adult ADHD. This study will testify to the effect of CBT and explore the efficacy of subsequent booster sessions on adult ADHD. Methods/Design: It is a three-armed randomized controlled trial to evaluate the efficacy of 12 weeks of CBT based on the published and validated manual and its booster sessions. The 12 weeks of CBT will be conducted weekly and will end at the 12th week, and then the booster sessions will be conducted monthly and end at the 24th week. There are three randomized groups, including a CBT with booster sessions group, a CBT group and a waiting group. Participants are outpatients of the Peking University Sixth Hospital who are diagnosed as having adult ADHD. The Primary efficacy endpoints are the scores of ADHD core symptoms at 12 and 24 weeks. Secondary endpoints include emotion, executive function, self-esteem, life quality and functional magnetic resonance imaging (fMRI) data at different time points, and the change within every group will also be analyzed. Discussion: This is the first study to explore the efficacy of booster sessions of CBT in adult ADHD as far as we know. The results might increase proof of efficacy of CBT for adult ADHD in China, and the results showing efficacy of the booster sessions would also benefit our clinical practice.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Zinc in the therapy of the attention-deficit/hyperactivity disorder in children. A preliminar randomized controlled trial
    Zamora, Jose
    Velasquez, Alvaro
    Troncoso, Ledia
    Barra, Patricia
    Guajardo, Karen
    Castillo-Duran, Carlos
    ARCHIVOS LATINOAMERICANOS DE NUTRICION, 2011, 61 (03) : 242 - 246
  • [22] Current Status of Cognitive Behavioral Therapy for Adult Attention-Deficit Hyperactivity Disorder
    Knouse, Laura E.
    Safren, Steven A.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2010, 33 (03) : 497 - +
  • [23] Efficacy of cognitive behavioural therapy in medicated adults with attention-deficit/hyperactivity disorder in multiple dimensions: a randomised controlled trial
    Mei-Rong Pan
    Shi-Yu Zhang
    Sun-Wei Qiu
    Lu Liu
    Hai-Mei Li
    Meng-Jie Zhao
    Min Dong
    Fei-Fei Si
    Yu-Feng Wang
    Qiu-Jin Qian
    European Archives of Psychiatry and Clinical Neuroscience, 2022, 272 : 235 - 255
  • [24] Efficacy of cognitive behavioural therapy in medicated adults with attention-deficit/hyperactivity disorder in multiple dimensions: a randomised controlled trial
    Pan, Mei-Rong
    Zhang, Shi-Yu
    Qiu, Sun-Wei
    Liu, Lu
    Li, Hai-Mei
    Zhao, Meng-Jie
    Dong, Min
    Si, Fei-Fei
    Wang, Yu-Feng
    Qian, Qiu-Jin
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2022, 272 (02) : 235 - 255
  • [25] Effectiveness of an online dialectical behavior therapy skills training in adults with attention-deficit/hyperactivity disorder: A randomized controlled trial
    Ulusoy, Vahide
    Bilican, Isil
    Gormez, Aynur
    PSYCHOTHERAPY RESEARCH, 2025, 35 (03) : 469 - 485
  • [26] A randomized-controlled neurofeedback trial in adult attention-deficit/hyperactivity disorder
    Beatrix Barth
    Kerstin Mayer-Carius
    Ute Strehl
    Sarah N. Wyckoff
    Florian B. Haeussinger
    Andreas J. Fallgatter
    Ann-Christine Ehlis
    Scientific Reports, 11
  • [27] Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial
    Annelies A. J. Verlaet
    Berten Ceulemans
    Helene Verhelst
    Dirk Van West
    Tess De Bruyne
    Luc Pieters
    Huub F. J. Savelkoul
    Nina Hermans
    Trials, 18
  • [28] A randomized-controlled neurofeedback trial in adult attention-deficit/hyperactivity disorder
    Barth, Beatrix
    Mayer-Carius, Kerstin
    Strehl, Ute
    Wyckoff, Sarah N.
    Haeussinger, Florian B.
    Fallgatter, Andreas J.
    Ehlis, Ann-Christine
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [29] Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial
    Verlaet, Annelies A. J.
    Ceulemans, Berten
    Verhelst, Helene
    Van West, Dirk
    De Bruyne, Tess
    Pieters, Luc
    Savelkoul, Huub F. J.
    Hermans, Nina
    TRIALS, 2017, 18
  • [30] Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder
    Timothy E. Wilens
    Drugs, 2003, 63 : 2395 - 2411